Spectrum Pharmaceuticals (SPPI) PT Bumped to $6 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500, Nasdaq futures rise on tech boost
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- L3Harris CEO steps down amid conduct review, shares drop
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- BOJ eyeing September rate hike, faster pace of tightening, sources say
Spectrum Pharma (SPPI) Easily Tops Q1 Views
May 5, 2016 4:46 PM EDTSpectrum Pharma (NASDAQ: SPPI) reported Q1 EPS of ($0.14), $0.18 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $43.9 million versus the consensus estimate of $28.83 million.
Spectrum recorded non-GAAP net income of $0.3 million, or $0.01 per basic share and less than $0.01 per diluted share in the... More
